22/08/2026
ЁЯзРUnlocking Neuropathic Pain: A Complication of Diabetes
ЁЯСЙA Scientific Review on Recognition, Pathophysiology, Diagnosis and Contemporary Management of Painful Diabetic Neuropathy
тЬТя╕ПЁЯй║ЁЯжБDr. Rana S. P. Singh, MBBS, MD
Senior Physician & Cardio-Diabetologist
Patna, Bihar, India ЁЯЗоЁЯЗ│ ЁЯк╖
ЁЯл╡Abstract
is one of the most important chronic complications of diabetes mellitus and represents a major cause of morbidity, impaired mobility and deterioration in quality of life. Peripheral neuropathy commonly affects the feet and legs and may manifest as burning, tingling, electric-shock-like sensations, numbness, altered temperature perception and severe neuropathic pain. Current evidence indicates that approximately one-third to one-half of people with diabetes may develop peripheral neuropathy.
Painful diabetic peripheral neuropathy (PDPN) is particularly challenging because patients may experience significant pain despite apparently normal clinical findings in the early stages. The condition can disturb sleep, physical activity and psychological well-being and, when accompanied by loss of protective sensation, can contribute to unnoticed trauma, ulceration and infection.
The modern approach to diabetic neuropathy therefore extends beyond glycemic control. Comprehensive management includes optimization of glucose, weight, blood pressure and lipid parameters, regular neurological and foot assessment, identification of reversible contributors, lifestyle modification and appropriate pharmacological treatment of neuropathic pain. The 2026 Standards of Care in Diabetes recommend gabapentinoids, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants and sodium-channel blockers among the initial pharmacological approaches for neuropathic pain in diabetes.
ЁЯл╡1. Introduction
Diabetes mellitus is a systemic metabolic disorder with consequences extending far beyond hyperglycemia. Among its chronic complications, diabetic neuropathy occupies a particularly important position because it can affect sensory, motor and autonomic nerve function.
Peripheral neuropathy generally begins distally, most frequently involving the feet and legs, and may subsequently involve the hands. Patients may describe burning, pins-and-needles sensations, numbness, shooting pain, hypersensitivity or a feeling of walking on cotton. Symptoms are often more troublesome at night.
Painful diabetic neuropathy is not simply a symptom to be tolerated. Persistent neuropathic pain can interfere with sleep, mobility, work, emotional health and overall quality of life. Recognition and treatment should therefore be an integral component of comprehensive diabetes care.
2. Pathophysiology: Why Do the Nerves Hurt?
The pathogenesis of diabetic neuropathy is multifactorial. Chronic metabolic abnormalities associated with diabetes can injure peripheral nerves as well as the small blood vessels supplying them. Persistent hyperglycemia and abnormalities in lipid metabolism contribute to oxidative and metabolic stress, vascular dysfunction and progressive neuronal injury.
Several mechanisms contribute to neuropathic pain:
Chronic hyperglycemia and metabolic stress
Oxidative stress and mitochondrial dysfunction
Microvascular impairment of the vasa nervorum
Abnormal neuronal excitability
Small-fiber and large-fiber dysfunction
Neuroinflammatory mechanisms
Associated cardiovascular and metabolic risk factors
Importantly, neuropathy is not determined by glucose alone. Obesity, hypertension, dyslipidemia, kidney disease, smoking and other metabolic factors can increase risk.
3. Clinical Spectrum
Diabetic neuropathy is heterogeneous and may present in several forms.
ЁЯк╖A. Distal Symmetric Peripheral Neuropathy
This is the most common clinical pattern. It typically produces a тАЬstockingтАЭ distribution of sensory symptoms involving the feet and lower limbs and, with progression, the hands.
Symptoms may include:
Burning pain
Tingling and тАЬpins and needlesтАЭ
Electric-shock-like pain
Numbness
Allodynia or pain from normally non-painful touch
Loss of vibration or temperature sensation
Muscle weakness in advanced disease
Impaired balance and gait
ЁЯк╖B. Autonomic Neuropathy
Autonomic nerve involvement can affect multiple organ systems, including cardiovascular, gastrointestinal, genitourinary and sudomotor function. Cardiovascular autonomic neuropathy may manifest with resting tachycardia, exercise intolerance or postural blood-pressure abnormalities.
ЁЯк╖C. Focal Neuropathies
Individual nerves may become affected, producing localized weakness, sensory symptoms or pain.
ЁЯк╖D. Proximal Neuropathy
Diabetic proximal neuropathy is less common but may cause severe pain involving the hip, buttock or thigh, accompanied by weakness and sometimes weight loss.
4. Recognizing Painful Diabetic Neuropathy
A critical clinical message is that pain and sensory loss do not always occur together.
A patient may have severe burning pain with relatively preserved sensation, while another may have profound loss of protective sensation with little or no pain.
A detailed history should therefore assess:
Character and distribution of pain
Onset and duration
Nocturnal worsening
Burning, shooting or electric sensations
Numbness and altered temperature perception
Sleep disturbance
Functional limitation
Foot injuries or recurrent ulcers
Symptoms suggestive of autonomic dysfunction
Current medications and potential adverse effects
5. Clinical Examination and Diagnosis
Diagnosis is predominantly clinical, supported by neurological and foot examination.
Assessment may include:
10-g monofilament testing
Vibration perception using a 128-Hz tuning fork
Pinprick or temperature sensation
Ankle reflexes
Muscle strength
Gait and balance
Inspection of the feet for calluses, deformity, ulceration or infection
Assessment of peripheral pulses and vascular status
People with diabetes should undergo regular assessment for peripheral neuropathy and foot complications.
Looking for alternative or additional causes
Not every neuropathy in a person with diabetes is necessarily caused by diabetes.
Depending upon the clinical presentation, evaluation may include consideration of:
Vitamin B12 deficiency
Thyroid dysfunction
Renal disease
Alcohol-related neuropathy
Medication-related neuropathy
Nutritional deficiency
Entrapment neuropathies
Other neurological disorders
Vitamin B12 assessment is particularly relevant in selected patients receiving long-term metformin therapy because low B12 levels may contribute to neuropathic manifestations.
Nerve-conduction studies and electromyography may be useful when the diagnosis is uncertain, the presentation is atypical, or another neurological disorder needs to be excluded.
6. The Cornerstone: Comprehensive Risk-Factor Management
Successful treatment begins with addressing the underlying metabolic environment.
The 2026 Standards of Care in Diabetes recommend optimizing glucose management and also addressing weight, blood pressure and lipid abnormalities to prevent or slow progression of diabetic neuropathy.
Therefore, the management plan should encompass:
Glycemic control + Blood pressure control + Lipid management + Weight management + Physical activity + Smoking cessation + Foot care
It is important, however, to explain to patients that pain-relieving medicines primarily treat the symptom of neuropathic pain; they do not necessarily reverse established nerve damage.
7. Pharmacological Management of Neuropathic Pain
The treatment of painful diabetic neuropathy should be individualized according to pain severity, age, renal and hepatic function, cardiovascular status, sleep disturbance, mood disorders, concomitant medications and potential adverse effects.
Current guidelines identify several effective medication classes.
Gabapentinoids
Pregabalin and gabapentin can reduce neuropathic pain in appropriate patients. Dose selection and adjustment require particular attention to renal function and tolerability.
Serotonin-Norepinephrine Reuptake Inhibitors
Duloxetine and selected other SNRIs have demonstrated efficacy in painful diabetic neuropathy and may be particularly useful when neuropathic pain coexists with mood symptoms.
Tricyclic Antidepressants
Agents such as amitriptyline, nortriptyline and imipramine may provide meaningful analgesia but require careful patient selection because of anticholinergic, cardiac and other adverse effects.
Sodium-Channel Blockers
Selected sodium-channelтАУacting agents are also recognized as therapeutic options in current guidelines.
Topical therapies
Topical approaches, including selected local anesthetic preparations, can be considered in appropriate patients, particularly when pain is localized.
A key principle is individualization rather than polypharmacy by default. If one medication class is ineffective or poorly tolerated, switching to another appropriate class may be preferable to simply escalating ineffective treatment. The American Academy of Neurology specifically advises against opioids for painful diabetic neuropathy because of their unfavorable risk-benefit profile.
8. Non-Pharmacological Management
Medication is only one component of care.
Regular physical activity, appropriate exercise, weight management, nutritional optimization, sleep improvement and psychological support may contribute substantially to overall outcomes.
Physical therapy may be especially valuable in patients with weakness, impaired balance or gait disturbance.
A multidisciplinary approach involving the physician, diabetes educator, physiotherapist, podiatric/foot-care professional and other specialists may be beneficial in patients with advanced complications.
9. The Diabetic Foot: Where Neuropathy Becomes Dangerous
Loss of protective sensation can transform a minor injury into a major clinical problem.
A patient who cannot feel a blister, foreign object inside footwear or thermal injury may continue walking on the affected foot. Repeated trauma can lead to ulceration, infection and, in severe cases, limb-threatening complications.
Every patient with diabetic neuropathy should therefore be educated regarding:
Daily foot inspection
Appropriate footwear
Avoidance of walking barefoot
Prompt attention to cuts, blisters or ulcers
Regular professional foot examination
Early treatment of infection or skin breakdown
The diabetic foot should never be an afterthoughtтАФit is an essential component of neuropathy management.
10. A Practical Clinical Approach
A useful clinical framework can be remembered as:
тАЬSEARCH тАУ ASSESS тАУ CONTROL тАУ RELIEVE тАУ PROTECTтАЭ
SEARCH
Look actively for neuropathy; do not wait for the patient to volunteer symptoms.
ASSESS
Determine sensory loss, pain severity, autonomic symptoms and foot risk.
CONTROL
Optimize glucose, blood pressure, lipids, weight and other modifiable risk factors.
RELIEVE
Treat neuropathic pain with an individualized, evidence-based pharmacological and non-pharmacological strategy.
PROTECT
Educate about foot care, falls, footwear and early reporting of injuries.
11. The Cardio-Diabetology Perspective
Diabetic neuropathy should not be viewed in isolation from cardiovascular disease.
Diabetes, hypertension, dyslipidemia, obesity and vascular dysfunction frequently coexist and contribute to a common cardiometabolic burden. A comprehensive consultation should therefore address the patient's whole cardiovascular-metabolic profile, rather than treating neuropathic pain as an isolated complaint.
For the cardio-diabetologist, neuropathy can also serve as a clinical reminder that the patient's diabetes requires comprehensive risk-factor assessment and long-term preventive care.
ЁЯСМ12. Conclusion
Painful diabetic neuropathy is a common, under-recognized and potentially disabling complication of diabetes mellitus. Its significance extends beyond pain: sensory loss can lead to falls and foot injury, while chronic pain may impair sleep, mobility, psychological well-being and quality of life.
Modern management requires a patient-centered, multidimensional approachтАФearly recognition, regular neurological and foot assessment, optimization of metabolic and cardiovascular risk factors, appropriate treatment of neuropathic pain, lifestyle intervention and continuous patient education.
The goal is not merely to make the patient тАЬpain-free.тАЭ The larger objective is to preserve sensation and function, prevent ulcers and disability, improve quality of life, and reduce the long-term burden of diabetes.
тАЬIn diabetic neuropathy, early recognition is prevention, comprehensive care is protection, and compassionate pain management is a vital part of healing.тАЭ
Author:
ЁЯжБDr. Rana S. P. Singh, MBBS, MD
Senior Physician & Cardio-Diabetologist
Patna, Bihar, India ЁЯЗоЁЯЗ│ ЁЯк╖
ЁЯжБDC ЁЯСЙFIRST AID EDUCATION AND EMERGENCY RELIEF (2025-26)
ЁЯжБLIONS CLUB INTERNATIONAL DISTRICT 322E
ЁЯжБ LIONS CLUB Of PATLIPUTRA ASTHA
ЁЯЫСNote -This article is intended for professional/educational purposes and does not replace individualized clinical assessment or prescription by a qualified physician.
